Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis

Journal of Clinical Lipidology

Volumn 7, Issue 2, 2013, Pages 109-116

  Nenseter, Marit S ^a,b   Narverud, Ingunn ^a,c,d   Græsdal, Asgeir ^e   Bogsrud, Martin P ^a,f   Aukrust, Pål ^a,b,g   Retterstøl, Kjetil ^a   Ose, Leiv ^a   Halvorsen, Bente ^b,g   Holven, Kirsten B ^c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO METROPOLITAN UNIVERSITY   (Norway)

^e Vestfold Center of Internal Medicine   (Norway)

^f Møre and Romsdal Hospital Trust   (Norway)

^g UNIVERSITY OF OSLO   (Norway)

Author keywords

ABCA1; ABCG1; Cholesterol efflux; Familial hypercholesterolemia; LDL apheresis; SR BI

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR BI;

ADOLESCENT; ADULT; ALLELE; APHERESIS; ARTICLE; CHILD; CHOLESTEROL EFFLUX; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE EXPRESSION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LOW DENSITY LIPOPROTEIN APHERESIS; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCHOOL CHILD;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; APOLIPOPROTEIN A-I; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD COMPONENT REMOVAL; CELL LINE; CHILD; CHOLESTEROL, HDL; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; LEUKOCYTES, MONONUCLEAR; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS B; YOUNG ADULT;

EID: 84874113397     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2012.08.001     Document Type: Article

References (22)

1. M.S. Brown, and J.L. Goldstein A receptor-mediated pathway for cholesterol homeostasis Science 232 1986 34 47 (Pubitemid 16037973)
2. M.A. Austin, C.M. Hutter, R.L. Zimmern, and S.E. Humphries Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review Am J Epidemiol 160 2004 407 420 (Pubitemid 39166973)
3. K.H. Weisgraber, T.L. Innerarity, and Y.M. Newhouse Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins Proc Natl Acad Sci U S A 85 1988 9758 9762 (Pubitemid 19027204)
4. J.F. Oram, and R.M. Lawn ABCA1. The gatekeeper for eliminating excess tissue cholesterol J Lipid Res 42 2001 1173 1179 (Pubitemid 32744239)
5. N. Wang, D. Lan, W. Chen, F. Matsuura, and A.R. Tall ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins Proc Natl Acad Sci U S A 101 2004 9774 9779 (Pubitemid 38869312)
6. D.L. Williams, M.A. Connelly, and R.E. Temel Scavenger receptor BI and cholesterol trafficking Curr Opin Lipidol 10 1999 329 339 (Pubitemid 29419690)
7. P.G. Yancey, A.E. Bortnick, G. Kellner-Weibel, M. de la Llera-Moya, M.C. Phillips, and G.H. Rothblat Importance of different pathways of cellular cholesterol efflux Arterioscler Thromb Vasc Biol 23 2003 712 719 (Pubitemid 36566157)
8. I.O. Ottestad, B. Halvorsen, and T.R. Balstad Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release or to promote cholesterol efflux J Nutr 136 2006 877 881
9. N. Bellanger, A. Orsoni, and Z. Julia Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia Arterioscler Thromb Vasc Biol 31 2011 1675 1681
10. G.R. Thompson, A. Catapano, and S. Saheb Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe Curr Opin Lipidol 21 2010 492 498
11. S. Schmaldienst, S. Banyai, and T.M. Stulnig Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolaemia Atherosclerosis 151 2000 493 499 (Pubitemid 30618766)
12. A.A. Kroon, M.A. van't Hof, P.N. Demacker, and A.F. Stalenhoef The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels Atherosclerosis 152 2000 519 526
13. A. Orsoni, S. Saheb, and J.H. Levels LDL-apheresis depletes apoE-HDL and pre{beta}-1 HDL in Familial Hypercholesterolemia: relevance to atheroprotection J Lipid Res 52 2011 2304 2313
14. A. Orsoni, E.F. Villard, and E. Bruckert Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemia J Lipid Res 53 2012 767 775
15. A. Græsdal, M. Prøven Bogsrud, and K.B. Holven Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia J Clin Lipidol 6 2012 331 339
16. A. Schroeder, O. Mueller, and S. Stocker The RIN: an RNA integrity number for assigning integrity values to RNA measurements BMC Mol Biol 7 2006 3
17. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408 (Pubitemid 34164012)
18. A.V. Khera, M. Cuchel, and M. de la Llera-Moya Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis N Engl J Med 364 2011 127 135
19. S. Mosig, K. Rennert, and P. Büttner Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism BMC Med Genomics 1 2008 60
20. M. Cuchel, and D.J. Rader Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? Circulation 113 2006 2548 2555 (Pubitemid 43948034)
21. J. Koizumi, A. Inazu, and H. Fujita Removal of apolipoprotein E-enriched high density lipoprotein by LDL-apheresis in familial hypercholesterolaemia: a possible activation of the reverse cholesterol transport system Atherosclerosis 74 1988 1 8 (Pubitemid 18266538)
22. M.P. Adorni, F. Zimetti, and M. Puntoni Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis J Lipid Res 53 2012 984 989